ArticleBreast cancer (Tokyo, Japan)2026
A novel quantification method for automatic computation of breast density from mammography images using deep learning.
Article in Breast cancer (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo develop and validate a fully automated deep-learning pipeline that quantifies mammographic dense rate (MDR) on processed mammograms, and to characterize age-related MDR trajectories in large-scale screening cohort. MATERIALS AND
methodsSegmentation AI was built with a U-Net segmentation network. The AI model was trained with 300 mediolateral-oblique images (240 for training, 60 for testing) in which pectoral muscle, glandular and fatty tissue were manually annotated. Segmentation accuracy was evaluated with the DICE coefficient whether AI could extract the segment of gland, pectoral muscle and fatty tissue. MDR was calculated, using the AI model. MDR was defined as the proportion of glandular pixels whose intensity exceeded the mean intensity of the segmented pectoral muscle. For each 240,465 processed MLO images from 134,411 women aged 40–79 years acquired in the Yokohama municipal cancer-screening program between January 2019 and April 2022, MDR was calculated.
resultsThe segmentation model achieved DICE coefficient of 0.967. Mean age was 56.6 ± 11.2 years. Mean MDR was 31.7 ± 25.9% and the median MDR was 26.9%. MDR declined steeply from the early 40s to the late 50s, then plateaued. Longitudinal analysis revealed two distinct patterns; a rapidly decreasing group and a persistently high-density group. Increased MDR may serve as an imaging biomarker preceding cancer diagnosis.
conclusionThe proposed vendor-agnostic U-Net pipeline enables accurate, standardized MDR measurement on processed images of mammograms, eliminating observer variability. Large-scale deployment elucidated granular age-specific density dynamics and supports quantitative MDR as a practical tool for risk-adapted breast-cancer screening and personalized selection of adjunct imaging modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.